Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours Β· Estimated delivery Sep 27 - Oct 2
Week at a Glance: Key Highlights Dr Reddys rebrands semaglutide from Olymvig to Olymra after court intervention API prices surge 200300% in 15 days due to West Asia conflict CDSCO conducts nationwide inspections across 49 entities DCGI flags 26 unapproved fixed-dose combinations Biocon announces new CEO and avoids semaglutide market for now AIOCD confirms nationwide pharmacy bandh on May 11 Trademark Dispute: Dr Reddys Rebrands Semaglutide After Court Intervention Date: March 2627, 2026 A major legal battle unfolded as Novo Nordisk challenged Dr Reddys use of the brand name Olymvig for its semaglutide drug
Regulatory Considerations for Peptide Research In Canada, injectable peptides are regulated as prescription drugs
In patients without diabetes who are obese, a once-weekly injection of tirzepatide (Mounjaro, Eli Lilly) may help shed weight and improve some risk factors for CVD, including blood pressure and cholesterol levels as well as prediabetic status, results from the SURMOUNT 1 clinical trial show
Research shows Indians often develop type 2 diabetes at a BMI of 2325 a weight at which most Western medical guidelines wouldn't even consider screening for diabetes
US$ 28.31
US$ 21.91
US$ 26.19
